SCHEMBL25810288

SCHEMBL25810288

COCC(=O)N1CCC(C)(C)CC1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
CYP1A2 P05177 4/20 0.53
CYP2D6 P10635 11/20 0.50
CYP3A4 P08684 7/20 0.50
TSHR P16473 5/20 0.50
CYP2C9 P11712 3/20 0.50
USP2 O75604 4/20 0.49
CYP2C19 P33261 5/20 0.48
MAPK1 P28482 3/20 0.48
HIF1A Q16665 2/20 0.48
TP53 P04637 1/20 0.48
HSD17B10 Q99714 5/20 0.47
HPGD P15428 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17177204 0.90 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2D6CYP3A4TSHR
SCHEMBL13722312 0.86 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2D6CYP3A4TSHR
SCHEMBL24341884 0.85 ALDH1A1 (0.53) ALDH1A1CYP1A2CYP2D6CYP3A4TSHR
SCHEMBL277929 0.84 ALDH1A1 (0.55) ALDH1A1CYP1A2CYP2D6CYP3A4TSHR
SCHEMBL14010813 0.83
SCHEMBL8402970 0.83 ALDH1A1 (0.51) ALDH1A1CYP1A2CYP2D6CYP3A4TSHR
SCHEMBL25824954 0.82 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2D6CYP3A4TSHR
SCHEMBL25094298 0.82 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2D6CYP3A4TSHR
SCHEMBL14417828 0.81 NAMPT (0.42) ALDH1A1CYP1A2CYP2D6CYP3A4TSHR
SCHEMBL25824959 0.79 ALDH1A1 (0.42) ALDH1A1CYP1A2CYP2D6CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125737-A1 HETEROCYCLIC COMPOUNDS AND USE THEREOF SILEXON AI TECHNOLOGY CO., LTD. (CN) 2023-07-06 WO disclosed
WO-2023116763-A1 PYRIDAZINE COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 上海优理惠生医药有限公司 2023-06-29 WO disclosed